2 Jul 2019

University partners with Bukwang Pharmaceutical Company to develop new drug treatment for Parkinson’s disease

The University of Dundee‘s Drug Discovery Unit (DDU) has announced a multi-million-pound partnership with Korean-based Bukwang Pharmaceutical Company in a bid to develop a new drug treatment for Parkinson’s disease. This announcement builds upon existing drug discovery partnerships the DDU has with Takeda and GSK. Parkinson’s disease is the second most common neurological disorder, after Alzheimer’s disease, affecting around two people in every 1000 across the population. There are around 6.1 million people worldwide and 120,000 people in the UK living with the condition. A key biol...

University partners with Bukwang Pharmaceutical Company to develop new drug treatment for Parkinson’s disease

25 Jun 2019

International Distinguished Scientist Award for Dundee Professor

Professor Graham Ogden, of the University of Dundee, has been awarded the 2019 IADR Distinguished Scientist Award in Oral Medicine & Pathology Research, one of the highest awards in dental research. Professor Ogden was presented with the accolade at the International Association for Dental Research (IADR) 97th General Session & Exhibition of the IADR, held in Vancouver. “I am deeply honoured to have received this award from IADR, which represents colleagues from around the world,” said Professor Ogden. “It is obviously very nice to be the focus of such recognition from one’s...

International Distinguished Scientist Award for Dundee Professor

24 Jun 2019

Intelligent testing could save lives by defusing ticking time bomb of liver disease

A new way of detecting liver disease decades before it can become fatal has been developed by a team of scientists at the University of Dundee and NHS Tayside. It comes as clinicians warn of a `ticking time bomb’ of alcohol-related and obesity-related liver diseases. Liver disease, which is notoriously asymptomatic, has become the second most common cause of death in under 65 year-olds in the UK. Unlike other common causes of death which have begun to decline in recent years, the age-standardised mortality rates for liver disease have risen by nearly 600% since the 1970s. Liver function is routinely ...

Intelligent testing could save lives by defusing ticking time bomb of liver disease

19 Jun 2019

Dundee placed in world’s top 100 for research quality

The University of Dundee is one of the world’s top 100 universities for research quality, according to a major survey released today (June 19). The Nature Index 2019 tracks contributions to research articles published in 82 high-quality natural science journals, chosen by an independent group of researchers. For the first time, the Nature Index has produced a normalised ranking which takes an institution’s size into account when calculating the output of high-quality research. In this table Dundee ranks 84th in the world. Professor Andrew Atherton, Principal and Vice-Chancellor of the Universit...

Dundee placed in world’s top 100 for research quality

11 Jun 2019

Boehringer Ingelheim and University of Dundee highlight successful PROTAC drug discovery program

Boehringer Ingelheim and University of Dundee achieve milestone in collaboration aimed at developing novel protein degradation medicines Results published in Nature Chemical Biology showcase the use of the broadly applicable structure-based PROTAC design approach to discover highly potent and selective drug candidates The first PROTAC is made freely available via Boehringer Ingelheim’s open innovation portal, opnMe Structure-based PROTAC design promises to accelerate the development of therapies against currently intractable cancer drivers Boehringer Ingelheim and the University of Dundee have exte...

Boehringer Ingelheim and University of Dundee highlight successful PROTAC drug discovery program